Author:
Nagata Takuya,Satou Tadaaki,Hayashi Shinichiro,Satyal Prabodh,Watanabe Manabu,Riggs Brannick,Saida Yoshihisa
Abstract
Abstract
Objective
Although cancer therapy suppresses recurrence and prolongs life, it may be accompanied by strong side effects; thus, there is a strong demand for the development effective treatments with fewer side effects. Cancer therapy using plant-derived essential oils is attracting attention as one promising method. This study investigated the antitumor effects of essential oil volatiles on breast cancer cells and identifies four essential oils that display antitumor activity.
Methods
Breast cancer cells were cultured in a 96-well plate, then one of twenty essential oils was added dropwise to the central well. The plate was incubated at 37 °C for 48 h and the effect of the volatile components of each essential oil on the surrounding breast cancer cell growth ability was examined using an MTT assay. Gas chromatography was used to investigate the concentration of the transpiration components that may affect cancer cells.
Results
Of the 20 essential oils, Lemongrass, Lemon myrtle, Litsea, and Melissa displayed strong anti-tumor effects. These essential oils inhibited the growth of nearby breast cancer cells, even when diluted more than 500-fold. The transpiration component of lemon Myrtle showed the strongest antitumor effect, but was the least cytotoxic to mononuclear cells in normal peripheral blood (PBMC). Each of these essential oils contained a very large amount of citral. The IC50 against breast cancer cells when citral was volatilized from each essential oil was 1.67 µL/mL for geranial and 1.31 µL/mL for neral. Volatilized citral alone showed strong anti-proliferation and infiltration-inhibiting effects.
Conclusion
The transpiration components of Lemongrass, Lemon myrtle, Litsea, and Melissa are thought to inhibit breast cancer cell proliferation due to their high levels of citral.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Cancer statistics and graph database. Center for the cancer control and information services. 2021. Available from: http//www.ganjoho.jp/public/statistics/backnumber/2021_jp.html.
2. Shimoi T, Nagai S, Yoshinami T, Takahashi M, Arioka H, et al. The Japanese breast cancer society clinical practice guidelines for systemic treatment of breast cancer, 2018 edition. Breast Cancer. 2020;27:322–31.
3. Rosenkaimer S, Sieburg T, Winter L, Mavratzas A, Hoffman WK, et al. Adverse cardiovascular effects of anti-tumor therapies in patients with breast cancer: A single-center cross-sectional analysis. Anticancer Res. 2022;42:3075–84.
4. Christianson DW. Structural and chemical biology of terpenoid cyclases. Chem Rev. 2017;117:11570–648.
5. Salakhutdinov NF, Volcho KP, Yarovaya OI. Monoterpenes as a renewable source of biologically active compounds. Pure Appl Chem. 2017;89:1105–17.